BERTINARIA, Massimo

BERTINARIA, Massimo  

SCIENZA E TECNOLOGIA DEL FARMACO  

Mostra records
Risultati 1 - 20 di 28 (tempo di esecuzione: 0.035 secondi).
Titolo Data di pubblicazione Autore(i) File
A multitarget approach to optimize the safety profile of coxibs: lumiracoxib derivatives with dual cyclooxygenase-2 inhibitor-thromboxane A2 receptor antagonist activity 2013 Malvina Hoxha; Valerie Capra; Carola Buccellati; Angelo Sala; Mohammed Abrar Abdul Gaffar Shaikh; Clara Cena; Roberta Fruttero; Alberto Gasco; G. Enrico Rovati; Massimo Bertinaria
Carnosine analogues containing Phenol substructures 2012 Giorgis M.; Bertinaria M.; Rolando B.; Montanaro G.; Fruttero R.; Gasco A.
Design and synthesis of encorafenib-based BRAF-V600E degraders 2022 Federica Blua, Marco Marino, Simone Gastaldi, Federica Maione, Eleonora Gianquinto, Federica Di Nicolantonio, Massimo Bertinaria
Design and synthesis of SWIR emitters for optical imaging 2022 Federica Blua, Mariangela Boccalon, Barbara Rolando, Roberta Napolitano, Massimo Bertinaria
Design, Synthesis and Pharmacological Evaluation of Anti-Pyroptotic Compounds Acting on NLRP3 Inflammasome Signaling Pathway: a New Start for Anti-Inflammatory Drugs? 2014 Bertinaria Massimo; Cocco Mattia; Garella Davide; Marini Elisabetta; Di Stilo Antonella; Miglio Gianluca
Design, synthesis and selection of INF200, a new non-sulfonylurea based NLRP3 inhibitor 2023 Federica Blua, Eleonora Gianquinto, Maria Concetta Granieri, Valentina Boscaro, Massimo Bertinaria
Different multitarget approaches to manage coxibs associatedcardiovascular risk. Design and synthesis of new lumiracoxibderivatives 2012 M. Bertinaria; M. A. A. G. Shaikh; C. Cena; B. Rolando; L. Lazzarato; R. Fruttero; A. Gasco; G. E. Rovati; C. Buccellati; V. Capra; A. Sala
Do P2Y12 receptor antagonism and NLRP3 inhibition exert additive cardioprotective effects against ischemia/reperfusion injury? 2019 Fausto Chiazza, Saveria Femminò, Debora Collotta, Elisa Zicola, Manuela Aragno, Massimo Bertinaria, Pasquale Pagliaro, Claudia Penna, Massimo Collino
EVALUATION OF THE ANTIPYROPTOTIC ACTIVITY OF NEW INFLAMMASOME INHIBITORS 2021 Boscaro Valentina, Gastaldi Simone, Bertinaria Massimo, Gallicchio Margherita
EXPLORING THE AMYLOID BETA (ABETA) DEPENDENT METABOLIC FINGERPRINT OF HIPPOCAMPAL NEURONS BY TWO-DIMENSIONAL COMPREHENSIVE GAS CHROMATOGRAPHY: POTENTIALS IN DRUG DISCOVERY STUDIES 2014 Davide Bressanello; Davide Garella; Massimo Bertinaria; Andrea Marcantoni; Claudio Franchino; Gianluca Miglio; Stephen E. Reichenbach; Carlo Bicchi; Chiara Cordero
H3 Receptor Ligands: New Imidazole H3-antagonists Endowed with NO-Donor Properties 2002 M. BERTINARIA
Identification of Small Synthetic Anti-Pyroptotic Compounds 2013 G. Miglio; M. Bertinaria; M. Rogazzo; M. Cocco; D. Garella; A. Di Stilo; R. Fantozzi
In silico study of NLRP3: towards selective inhibition with small molecules 2019 Alejandro Gómez García, Simone Gastaldi, Giulia Fumero, Massimo Bertinaria, José Luis Medina Franco
In the search for new NLRP3 inhibitors: chemical modulation of the 1-(piperidin-4-yl)-1,3-dihydro-2 Hbenzo[d]imidazole-2-one scaffold 2021 Simone Gastaldi, Valentina Boscaro, Eleonora Gianquinto, Christina F. Sandall, Marta Giorgis, Elisabetta Marini, Federica Blua, Margherita Gallicchio, Francesca Spyrakis, Justin A. MacDonald, Massimo Bertinaria
Inhibition of NLRP3 ATPase activity: a new strategy to fight chronic inflammatory diseases 2019 Simone Gastaldi, Federica Blua, Marta Giorgis, Elisabetta Marini, Massimo Bertinaria
Is NLRP3 inflammasome a new pharmacological target in myocardial ischemia/reperfusion injury? 2015 Femminò, S; Chiazza, F; Mastrocola, R; Tullio, F; Penna, C; Nigro, D; Alloatti, G; Cocco, M; Garella, D; Bertinaria, M; Fantozzi, R; Aragno, M; Collino, M; Pagliaro, P
NEW NON-COVALENT INHIBITORS OF NLRP3 INFLAMMASOME ATPASE ACTIVITY 2019 Gastaldi, S; Marino, M.; Giorgis, M.; Marini, E.; Boscaro, V.; Gallicchio, M.; Bertinaria, M.
New tools for the development of direct NLRP3 inflammasome inhibitors 2018 Elisabetta Marini, Marta Giorgis, Massimo Bertinaria
NO-donor Carnosine Derivatives As Potential Neuroprotective Agents 2011 Montanaro G.; Bertinaria M.; Giorgis M.; Rolando B.; Fruttero R.; Gasco A.
Pharmacological characterization of new NLRP3 inflammasome inhibitors. 2019 Valentina Boscaro, Simone Gastaldi, Marco Marino, Marta Giorgis, Elisabetta Marini, Massimo Bertinaria, Margherita Gallicchio